Total Payments
$7,570
2024 Payments
$1,749
Companies
29
Transactions
487
Medicare Patients
1,657
Medicare Billing
$437,629
Payment Breakdown by Category
Food & Beverage$7,425 (98.1%)
Education$144.61 (1.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,425 | 482 | 98.1% |
| Education | $144.61 | 5 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,087 | 89 | $0 (2024) |
| Alkermes, Inc. | $810.61 | 50 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $720.82 | 43 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $527.98 | 34 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $442.70 | 23 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $413.13 | 39 | $0 (2022) |
| Allergan, Inc. | $350.19 | 28 | $0 (2020) |
| Lundbeck LLC | $342.14 | 22 | $0 (2024) |
| ITI, Inc. | $276.97 | 18 | $0 (2023) |
| Shire North American Group Inc | $269.88 | 21 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,749 | 98 | Otsuka America Pharmaceutical, Inc. ($250.54) |
| 2023 | $1,524 | 93 | ABBVIE INC. ($329.63) |
| 2022 | $656.87 | 45 | ABBVIE INC. ($204.74) |
| 2021 | $1,091 | 78 | AbbVie Inc. ($320.13) |
| 2020 | $590.40 | 40 | Allergan, Inc. ($164.15) |
| 2019 | $958.03 | 69 | Alkermes, Inc. ($148.80) |
| 2018 | $711.56 | 44 | Shire North American Group Inc ($156.52) |
| 2017 | $289.66 | 20 | Otsuka America Pharmaceutical, Inc. ($120.36) |
All Payment Transactions
487 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $9.28 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/18/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: CNS | ||||||
| 12/16/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: OUD | ||||||
| 12/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.86 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $35.14 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 11/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $8.75 | General |
| Category: PSYCHIATRY | ||||||
| 11/10/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: PSYCHIATRY | ||||||
| 11/09/2024 | Neurocrine Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $92.97 | General |
| 11/08/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $116.78 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/02/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Central Nervous System | ||||||
| 10/31/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $2.31 | General |
| Category: PSYCHIATRY | ||||||
| 10/28/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: PSYCHIATRY | ||||||
| 10/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.74 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $26.48 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/21/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $9.74 | General |
| Category: PSYCHIATRY | ||||||
| 10/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: NEUROSCIENCE | ||||||
| 10/06/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: SCHIZOPHRENIA | ||||||
| 10/03/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $8.83 | General |
| Category: PSYCHIATRY | ||||||
| 10/01/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: PSYCHIATRY | ||||||
| 09/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.93 | General |
| Category: NEUROSCIENCE | ||||||
| 09/23/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 671 | 2,705 | $642,059 | $224,644 |
| 2022 | 9 | 440 | 1,385 | $232,842 | $98,198 |
| 2021 | 7 | 228 | 882 | $138,781 | $56,446 |
| 2020 | 7 | 318 | 1,042 | $157,420 | $58,341 |
Total Patients
1,657
Total Services
6,014
Medicare Billing
$437,629
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90837 | Psychotherapy, 1 hour | Office | 2023 | 124 | 842 | $168,703 | $66,577 | 39.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 214 | 813 | $126,439 | $61,913 | 49.0% |
| 90868 | Treatment using magnetic field to stimulate nerve cells in brain, subsequent delivery and management | Office | 2023 | 12 | 413 | $247,800 | $51,503 | 20.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 57 | 145 | $30,921 | $13,912 | 45.0% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 60 | 143 | $16,306 | $7,195 | 44.1% |
| 90791 | Psychiatric diagnostic evaluation | Office | 2023 | 62 | 65 | $13,000 | $6,530 | 50.2% |
| 90832 | Psychotherapy, 30 minutes | Office | 2023 | 42 | 125 | $12,555 | $4,910 | 39.1% |
| 90834 | Psychotherapy, 45 minutes | Office | 2023 | 35 | 78 | $11,755 | $4,192 | 35.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 24 | 24 | $6,930 | $3,585 | 51.7% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 12 | 12 | $2,700 | $1,623 | 60.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 16 | 21 | $1,890 | $1,377 | 72.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 24 | $3,060 | $1,327 | 43.4% |
| 90837 | Psychotherapy, 1 hour | Office | 2022 | 75 | 501 | $100,200 | $39,185 | 39.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 173 | 517 | $80,122 | $36,080 | 45.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 45 | 97 | $12,125 | $4,984 | 41.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 39 | 39 | $8,775 | $4,756 | 54.2% |
| 90834 | Psychotherapy, 45 minutes | Office | 2022 | 32 | 87 | $13,050 | $4,532 | 34.7% |
| 90832 | Psychotherapy, 30 minutes | Office | 2022 | 26 | 77 | $7,700 | $2,918 | 37.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 17 | 22 | $4,620 | $2,589 | 56.0% |
| 90791 | Psychiatric diagnostic evaluation | Office | 2022 | 19 | 20 | $4,000 | $1,932 | 48.3% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 14 | 25 | $2,250 | $1,222 | 54.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 86 | 329 | $50,970 | $21,788 | 42.7% |
| 90837 | Psychotherapy, 60 minutes | Office | 2021 | 32 | 251 | $50,200 | $19,912 | 39.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 56 | 216 | $27,000 | $10,209 | 37.8% |
| 90834 | Psychotherapy, 45 minutes | Office | 2021 | 16 | 35 | $5,250 | $1,760 | 33.5% |
About Dr. Scott Gilchrist, MD
Dr. Scott Gilchrist, MD is a Psychiatry healthcare provider based in Weston, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/30/2010. The National Provider Identifier (NPI) number assigned to this provider is 1255656468.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Gilchrist, MD has received a total of $7,570 in payments from pharmaceutical and medical device companies, with $1,749 received in 2024. These payments were reported across 487 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($7,425).
As a Medicare-enrolled provider, Gilchrist has provided services to 1,657 Medicare beneficiaries, totaling 6,014 services with total Medicare billing of $437,629. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Weston, WV
- Active Since 03/30/2010
- Last Updated 07/10/2014
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1255656468
Products in Payments
- VRAYLAR (Drug) $1,422
- REXULTI (Drug) $746.94
- ARISTADA (Drug) $562.73
- TRINTELLIX (Drug) $505.18
- CAPLYTA (Drug) $461.16
- LATUDA (Drug) $413.13
- SPRAVATO (Drug) $393.33
- NEUROSTAR TMS THERAPY (Device) $232.83
- Azstarys (Drug) $224.90
- SUBLOCADE (Drug) $220.24
- Auvelity (Drug) $188.42
- NUEDEXTA (Drug) $185.69
- VYVANSE (Drug) $181.24
- Dyanavel XR (Drug) $151.47
- ABILIFY MAINTENA (Drug) $138.60
- Adzenys XR-ODT (Drug) $114.65
- MYDAYIS (Drug) $114.55
- Vivitrol 380 mg (Drug) $100.12
- Austedo XR (Drug) $87.08
- VIVITROL (Drug) $80.82
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Weston
Carlos Salgueiro, Md, MD
Psychiatry — Payments: $7,628
Psychiatry $7,628
Mrs. Monica Salgueiro, M.d, M.D
Psychiatry — Payments: $7,466
Psychiatry $7,466
Dr. Edwin Gomez, M.d, M.D
Psychiatry — Payments: $4,316
Psychiatry $4,316
Shalini Katyal, M.d, M.D
Psychiatry — Payments: $1,323
Psychiatry $1,323
Fabio Catao Alves Martins Da Silva, M.d, M.D
Psychiatry — Payments: $897.67
Psychiatry $897.67
Dr. Robert Gouthro, M.d, M.D
Psychiatry — Payments: $865.90
Psychiatry $865.90